Xing P - Search Results

1

LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.

Zhang W, Han L, Xing P, Liu B, Sun Z, Zhou W, Dong J. Zhang W, et al. Among authors: xing p. Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec;393(12):2543-2551. doi: 10.1007/s00210-020-01889-z. Epub 2020 May 21. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32435875

2

Clinical and biological significance of hepsin overexpression in breast cancer.

Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT, Wei XL. Xing P, et al. J Investig Med. 2011 Jun;59(5):803-10. doi: 10.2310/JIM.0b013e31821451a1. J Investig Med. 2011. PMID: 21383634

3

Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity.

Dong HT, Liu Q, Zhao T, Yao F, Xu Y, Chen B, Wu Y, Zheng X, Jin F, Li J, Xing P. Dong HT, et al. Among authors: xing p. Mol Ther Nucleic Acids. 2020 Mar 6;19:696-705. doi: 10.1016/j.omtn.2019.12.016. Epub 2019 Dec 24. Mol Ther Nucleic Acids. 2020. PMID: 31945728 Free PMC article.

4

Fascin, an actin-bundling protein, promotes breast cancer progression in vitro.

Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT, Wei XL. Xing P, et al. Cell Biochem Funct. 2011 Jun;29(4):303-10. doi: 10.1002/cbf.1750. Cell Biochem Funct. 2011. PMID: 21491467

5

Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.

Liu Q, Dong HT, Zhao T, Yao F, Xu Y, Chen B, Wu Y, Jin F, Xing P. Liu Q, et al. Among authors: xing p. Endocr Relat Cancer. 2022 Feb 4;29(3):139-149. doi: 10.1530/ERC-21-0243. Endocr Relat Cancer. 2022. PMID: 34935631

6

Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer.

Wang X, Wei X, Cao Y, Xing P. Wang X, et al. Among authors: xing p. J Cell Mol Med. 2022 Mar;26(5):1672-1683. doi: 10.1111/jcmm.17210. Epub 2022 Feb 7. J Cell Mol Med. 2022. PMID: 35132755 Free PMC article.

7

A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.

Xing P, Li J, Jin F. Xing P, et al. Med Oncol. 2010 Sep;27(3):926-31. doi: 10.1007/s12032-009-9308-7. Epub 2009 Sep 23. Med Oncol. 2010. PMID: 19771534

8

[Influence of the number of removed axillary lymph nodes on the prognosis of node-negative primary breast cancer].

Wang HY, Dong HT, Liu Q, Xing P, Li JG. Wang HY, et al. Among authors: xing p. Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):457-60. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22967449 Chinese.

9

Prognostic significance of body mass index in breast cancer patients with hormone receptor-positive tumours after curative surgery.

Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT, Wei XL. Xing P, et al. Clin Invest Med. 2013 Dec 1;36(6):E297-305. doi: 10.25011/cim.v36i6.20627. Clin Invest Med. 2013. PMID: 24309226 Clinical Trial.

10

The value of substratified combined imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses.

Li J, Xing P, Feng L, Dong H, Jin F, Wu Y, Zheng X. Li J, et al. Among authors: xing p. Breast Cancer Res Treat. 2014 Apr;144(2):391-6. doi: 10.1007/s10549-014-2863-4. Epub 2014 Feb 12. Breast Cancer Res Treat. 2014. PMID: 24519388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

834 results

Search Page

Filters